Time to update your table vis-à-vis Danuglipron BID. Extended-release (qD) Danuglipron still has a chance to work out, but it has to be considered a high-risk program at this point.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”